Supplier | Mylan Institutional LLC |
---|---|
Availability Status | QuicksortRx NDC Availability Disruption (2024-07-31) |
Status Description |
QuicksortRx has identified an availability disruption for this product across multiple channels. |
Quicksort Status | Availability Issues Detected (2024-07-14) |
ASHP Status | Product Available (2024-07-31) |
QUMI Product Code | h5w80rp (QuicksortRx Universal Medication Identifier) |
NDC | Package Count | Supplier | Description | Status | Updated |
---|---|---|---|---|---|
10 | Hikma Pharmaceuticals USA Inc. | Remifentanil 5 mg Vial [Ultiva] | ASHP Shortage + QS Availability Issues | 2024-07-25 | |
10 | Fresenius Kabi USA, LLC | Remifentanil 5 mg Vial [Ultiva] | ASHP Shortage + QS Availability Issues | 2024-08-10 | |
10 | Mylan Institutional LLC | Remifentanil 5 mg Vial [Ultiva] | No Availability Issues Detected |
Previous Status | Status Start Date | Status End Date |
---|---|---|
QuicksortRx NDC Availability Disruption | 2024-07-31 | Current |
No Availability Issues Detected | 2024-07-31 |
RXCUI: | 1729710 |
---|---|
Dosage Form: | Vial |
Dosage Route: | INJECTABLE |
Strength: | 10 |
Measure: | mg |
ANDA: | NDA020630 |
Generic Description: | REMIFENTANIL HCl |
DEA: | 2 |